Treating cancers associated with overexpression of her-2/neu

Details Treating cancers associated with overexpression of her-2/neu Treating cancers associated with overexpression of her-2/neu

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/365 (2006.01) A61K 31/635 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2357525

Cancers associated with overexpression of HER-2/neu are treated with a selective inhibitor of cyclooxygenase-2 as the sole treating agent or said inhibitor in combination regimen with HERCEPTIN~ and/or standard therapy. Uses include adjuvant therapy for HER-2/neu positive breast cancer and treatment of HER-2/neu positive breast cancer that has metastasized.

Les cancers associés à la surexpression de HER-2/neu sont traités avec un inhibiteur sélectif de cyclooxygénase-2 servant d'agent de traitement ou avec cet inhibiteur combiné avec HERCEPTIN~ et/ou une thérapie standard. L'invention trouve une application dans le traitement par additifs du cancer du sein positif HER-2/neu et dans le traitement du cancer du sein positif HER-2/neu métastasé.

Affiliated with

Also associated with

Rating

Treating cancers associated with overexpression of her-2/neu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating cancers associated with overexpression of her-2/neu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating cancers associated with overexpression of her-2/neu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1889160